The FDA has certified the plant for exports to the US.
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) announced today that it will hire 200 employees this year for its new plant in Har Hotzvim Jerusalem, after the US Food and Drug Administration (FDA) certified the plant for exports to the US. With the certification, Teva will hire 50 university graduates and 150 production staff, who will join the plant’s 300 current employees.
Two years ago, Teva built its second plant at Har Hotzvim, one of the company’s 38 plants worldwide. The plant is due to produce four billion tablets by year-end, and double production from 2008. The plant’s exports will amount to $700 million a year. Teva invested more than $100 million in the plant, which will produce over 100 compounds a year by year-end.
Published by Globes [online], Israel business news - www.globes.co.il - on April 4, 2007
© Copyright of Globes Publisher Itonut (1983) Ltd. 2007